NO20003073L - Farmasøytiske blandinger inneholdende mikroniserte bisykliske legemidler - Google Patents

Farmasøytiske blandinger inneholdende mikroniserte bisykliske legemidler

Info

Publication number
NO20003073L
NO20003073L NO20003073A NO20003073A NO20003073L NO 20003073 L NO20003073 L NO 20003073L NO 20003073 A NO20003073 A NO 20003073A NO 20003073 A NO20003073 A NO 20003073A NO 20003073 L NO20003073 L NO 20003073L
Authority
NO
Norway
Prior art keywords
drugs
pharmaceutical compositions
compositions containing
containing micronized
bicyclic
Prior art date
Application number
NO20003073A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003073D0 (no
Inventor
David Robert Dumpleton
Simon Joseph Holland
Wendy Anne Knight
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20003073D0 publication Critical patent/NO20003073D0/no
Publication of NO20003073L publication Critical patent/NO20003073L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
    • B02C17/04—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls with unperforated container
    • B02C17/06—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls with unperforated container with several compartments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
    • B02C17/18—Details
    • B02C17/20—Disintegrating members
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
    • B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
    • B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
    • B02C17/18—Details
    • B02C17/22—Lining for containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20003073A 1997-12-16 2000-06-15 Farmasøytiske blandinger inneholdende mikroniserte bisykliske legemidler NO20003073L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726543.3A GB9726543D0 (en) 1997-12-16 1997-12-16 Novel compositions
PCT/EP1998/008156 WO1999030687A1 (fr) 1997-12-16 1998-12-14 Preparations pharmaceutiques contenant des medicaments bicycliques micronises

Publications (2)

Publication Number Publication Date
NO20003073D0 NO20003073D0 (no) 2000-06-15
NO20003073L true NO20003073L (no) 2000-08-10

Family

ID=10823680

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003073A NO20003073L (no) 1997-12-16 2000-06-15 Farmasøytiske blandinger inneholdende mikroniserte bisykliske legemidler

Country Status (32)

Country Link
EP (2) EP1338274A1 (fr)
JP (1) JP2002508310A (fr)
KR (1) KR20010033149A (fr)
CN (2) CN1284865A (fr)
AP (1) AP2000001837A0 (fr)
AR (1) AR017212A1 (fr)
AT (1) ATE260094T1 (fr)
AU (1) AU743155B2 (fr)
BG (1) BG104596A (fr)
BR (1) BR9813602A (fr)
CA (1) CA2314968A1 (fr)
DE (1) DE69821978T2 (fr)
DZ (1) DZ2677A1 (fr)
EA (1) EA003732B1 (fr)
ES (1) ES2216350T3 (fr)
GB (1) GB9726543D0 (fr)
HU (1) HUP0100384A3 (fr)
ID (1) ID24930A (fr)
IL (1) IL136664A0 (fr)
MA (1) MA24721A1 (fr)
MY (1) MY132978A (fr)
NO (1) NO20003073L (fr)
NZ (1) NZ504991A (fr)
OA (1) OA11429A (fr)
PE (1) PE20000114A1 (fr)
PL (1) PL341339A1 (fr)
SK (1) SK9132000A3 (fr)
TR (1) TR200001792T2 (fr)
TW (1) TW200305442A (fr)
UY (1) UY25307A1 (fr)
WO (1) WO1999030687A1 (fr)
ZA (1) ZA9811502B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4990696A (en) 1995-02-24 1996-09-11 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
EP1294358B1 (fr) * 2000-06-28 2004-08-18 Smithkline Beecham Plc Procede de broyage par voie humide
GB0112497D0 (en) * 2001-05-22 2001-07-11 Smithkline Beecham Plc Formulation
GB0127805D0 (en) 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
KR20080066977A (ko) 2005-11-10 2008-07-17 더루우브리졸코오포레이션 분산체의 제조방법
CA2726878A1 (fr) * 2008-06-05 2009-12-10 Minster Research Limited Nouveaux traitements
WO2009147441A2 (fr) * 2008-06-05 2009-12-10 Minster Research Limited Nouveaux traitements
WO2011067607A1 (fr) * 2009-12-03 2011-06-09 Minster Research Ltd Traitement de maladies infectieuses
EP2506846A1 (fr) * 2009-12-03 2012-10-10 Proximagen Limited Traitement de l'allodynie et de l'hyperalgésie
EP2471513B1 (fr) * 2010-12-28 2015-06-10 LEK Pharmaceuticals d.d. Procédé de production d'ingrédients pharmaceutique actif et préparation sous la forme de billes
WO2016157061A1 (fr) * 2015-03-31 2016-10-06 Wockhardt Limited Procédé de broyage humide aseptique pour le palmitate de palipéridone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5065946A (en) * 1988-07-21 1991-11-19 Matsushita Electric Industrial Co., Ltd. Media agitating mill and method for milling ceramic powder
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
NZ248813A (en) * 1992-11-25 1995-06-27 Eastman Kodak Co Polymeric grinding media used in grinding pharmaceutical substances
DE69327965T2 (de) * 1992-12-11 2000-10-19 Smithkline Beecham Corp., Philadelphia Pharmazeutische zusammenstellung enthaltende bizyklisch typ verbindungen
DE69524871T2 (de) * 1994-06-10 2002-08-22 Smithkline Beecham P.L.C., Brentford Benzopyrans und deren verwendung als therapeutische mittel
US5534270A (en) * 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
US5518738A (en) * 1995-02-09 1996-05-21 Nanosystem L.L.C. Nanoparticulate nsaid compositions
DE19614295A1 (de) * 1995-04-21 1996-10-24 Friedrich Dr Ing Vock Verfahren und Vorrichtung zum Nassmahlen und Dispergieren von Feststoffpartikeln in Flüssigkeiten

Also Published As

Publication number Publication date
DE69821978T2 (de) 2004-12-23
BR9813602A (pt) 2002-01-22
CN1284865A (zh) 2001-02-21
WO1999030687A1 (fr) 1999-06-24
EA003732B1 (ru) 2003-08-28
CA2314968A1 (fr) 1999-06-24
EA200000664A1 (ru) 2000-12-25
SK9132000A3 (en) 2001-01-18
TW200305442A (en) 2003-11-01
DZ2677A1 (fr) 2003-03-29
AR017212A1 (es) 2001-08-22
EP1338274A1 (fr) 2003-08-27
DE69821978D1 (de) 2004-04-01
UY25307A1 (es) 2001-08-27
PL341339A1 (en) 2001-04-09
MA24721A1 (fr) 1999-07-01
OA11429A (en) 2004-04-26
AP2000001837A0 (en) 2000-06-30
KR20010033149A (ko) 2001-04-25
PE20000114A1 (es) 2000-04-30
JP2002508310A (ja) 2002-03-19
EP1037612B1 (fr) 2004-02-25
TR200001792T2 (tr) 2000-11-21
ZA9811502B (en) 2000-06-15
MY132978A (en) 2007-10-31
EP1037612A1 (fr) 2000-09-27
NZ504991A (en) 2002-11-26
AU2272499A (en) 1999-07-05
NO20003073D0 (no) 2000-06-15
ATE260094T1 (de) 2004-03-15
IL136664A0 (en) 2001-06-14
BG104596A (en) 2001-04-30
CN1475206A (zh) 2004-02-18
ES2216350T3 (es) 2004-10-16
HUP0100384A2 (hu) 2001-12-28
AU743155B2 (en) 2002-01-17
HUP0100384A3 (en) 2002-04-29
ID24930A (id) 2000-08-31
GB9726543D0 (en) 1998-02-11

Similar Documents

Publication Publication Date Title
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
DE69816471D1 (de) Pyrimidinon verbindungen und diese enthaltende pharmazeutische zusammenstellungen
ID24654A (id) Formulasi farmasi omeprazola
EE03664B1 (et) Farmatseutilised aerosoolkompositsioonid
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
CY2005007I1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
ATE422359T1 (de) Verbindungen und pharmazeutische zusammensetzungen mit appetitunterdrückender aktivität
PT981375E (pt) Composicoes farmaceuticas contendo proteinas do plasma
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
MA26549A1 (fr) Medicaments
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
DE69900561D1 (de) Pharmazeutische Zusammensetzungen enthaltend Mupirocin
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
NO20003073D0 (no) Farmasøytiske blandinger inneholdende mikroniserte bisykliske legemidler
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
ATE228839T1 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
ATE295150T1 (de) Pharmazeutische zusammensetzungen
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
MA26531A1 (fr) Composition pharmaceutique
DE69816124D1 (de) Pharmazeutische zusammensetzungen enthaltend zafirlukast
HUP9903375A3 (en) Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs
IL151529A0 (en) Pharmaceutical compositions containing micronized bicyclic drugs
NO994436L (no) Farmasöytiske sammensetninger
IL132784A0 (en) Pharmaceutical compositions containing dronabinol
HK1032195A (en) Pharmaceutical compositions containing micronized bicyclic drugs

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application